Á¶°üÇõ ´ëÇ¥ºÎ¿øÀå
¸Á¸·¼¾ÅÍÀå / ¾È°úÀü¹®ÀÇ / ¸Á¸·Àü¹®ÀÇ / Çѱ¹¸Á¸·ÇÐȸÁ¤È¸¿ø
¡¤ ¼¿ï´ëÇб³ Àǰú´ëÇÐ ÀÇÇйڻ硤 îñ¼¿ï´ëÇб³ Àǰú´ëÇÐ ¾È°úÇб³½Ç ¸Á¸·Àü¹®ÀÇ
- ºÐ´ç¼¿ï´ëÇб³º´¿ø ¸Á¸·ÀüÀÓÀÇ
¡¤ îñÀÇ·á¹ýÀÎ Çѱæ¾È°úº´¿ø ¸Á¸·¼¾ÅÍ °úÀå
- °¡Å縯°üµ¿Àǰú´ëÇÐ Á¶±³¼ö
¡¤ ¹Ì±¹ÀÇ»çÀÚ°Ý Ãëµæ(USMLE, New York State, United States)
¡¤ ¹Ì±¹ ´º¿å Ä÷³ºñ¾Æ Àǰú´ëÇÐ ¾È°ú ¿¬¼ö (Columbia University Medical Center, Edward S. Harkness Eye Institute, New York)
¡¤ ¸¶¸£ÄûÁî ÈĽºÈÄ(Marquis Who¡¯s Who) - ¼¼°è 3´ë Àθí»çÀü, ÀÇÇÐ ¾È°úºÐ¾ß µîÀç
¡¤ îñû¿Í´ë Àǹ«½Ç ±ºÀǰü(¼öµµ¹æÀ§»ç·ÉºÎ)
¼Ò¼ÓÇÐȸ
¡¤ Çѱ¹¸Á¸·ÇÐȸ º¸ÇèÀ§¿ø / ¼ö¿ø½Ã ÀÇ»çȸ ±âȹÀ̻硤 ´ëÇѾȰúÇÐȸ / Çѱ¹Æ÷µµ¸·ÇÐȸ / Çѱ¹¸Á¸·ÇÐȸ Á¤È¸¿ø
¡¤ ¹Ì±¹¾È°úÇÐȸ(AAO) / ¹Ì±¹½Ã°úÇבּ¸È¸(ARVO) Á¤È¸¿ø
¡¤ ¹Ì±¹ Journal of Clinical & Medical Images ³í¹®½É»çÀ§¿ø
¡¤ ¼ö¿ø½Ã ¾Æµ¿ÀÇ·áÁö¿ø»ç¾÷ ºÎÀ§¿øÀå
ÁÖ¿äÇÐȸ¹ßÇ¥
¡¤ 2014 ARVO in Orlando / 2015 AAO in Las Vegas¡¤ 2016 ARVO in Seattle / 2016 AAO in Chicago
¡¤ 2017 ASCRS in Los Angeles / 2017 APVRS in Kuala Lumpur
¡¤ 2016 ´ëÇѾȰúÇÐȸ Çмú»ó / 2017 ¾Æ½Ã¾ÆÅÂÆò¾ç¸Á¸·ÇÐȸ ¿ì¼ö¿¬±¸ÀÚ»ó (APVRS)
ÁÖ¿ä³í¹® : (SCI ³í¹® Á¦1ÀúÀÚ,Ã¥ÀÓÀúÀÚ¸¸ ±âÀç,Àü¼¼°è Top3 ¾È°ú³í¹® 10¿©Æí, ¸ñ·Ï÷ºÎ)
¡¤ ¸Á¸·³»Ãþ ºÒ±ÔÄ¢ Áö¼ö¸¦ ÀÌ¿ëÇÑ ¸Á¸·Àü¸·ÀÇ ¿¹ÈÄ ¿¹Ãø - ¹Ì±¹¾È°úÀú³Î(AJO) 2016¡¤ ¸Á¸·µ¿¸ÆÆó¼â ȯÀÚÀÇ Ç÷Àü ¾ç»ó ºÐ¼® - ¹Ì±¹¾È°úÀú³Î(AJO) 2016
¡¤ ¸Á¸·ºÐÁöÁ¤¸ÆÆó¼â ȯÀÚÀÇ ³úÇ÷°ü ³ªÀÌ ºÐ¼® - ¹Ì±¹½Ã°úÇÐÇÐȸÀú³Î(IOVS) 2017
¡¤ ¸Á¸·¹Ú¸® ȯÀÚÀÇ ¼ö¼ú ÈÄ ±¼Àý°ª º¯È - ¹Ì±¹¾È°úÀú³Î(AJO) 2014
- ±× ¿Ü 10¿©Æí Àú¼ú
ÃÖ±Ù SCI ³í¹® ¸ñ·Ï (Á¦ 1ÀúÀÚ, Ã¥ÀÓÀúÀÚ¸¸ ±âÀç)
1. Kim MS, Moon JH, Lee MW, Cho KH (2022), Analysis of postoperative intraocular pathologies in patients with mature cataracts. PLoS ONE 17(1): e0263352.2. Cho KH, Park SJ, Cho JH, Woo SJ, Park KH. Inner-retinal Irregularity Index Predicts Postoperative Visual Prognosis in Idiopathic Epiretinal Membrane. Am J Ophthalmol. 2016 Aug;168:139-49
3. Cho KH, Ahn SJ, Jung C, Han MK, Park KH, Woo SJ. Ischemic Injury of the Papillomacular Bundle Is a Predictive Marker of Poor Vision in Eyes with Branch Retinal Artery Occlusion. Am J Ophthalmol. 2016 Feb;162:107-120
4. Cho KH, Park IW, Kwon SI. Changes in postoperative refractive outcomes following combined phacoemulsification and pars plana vitrectomy for rhegmatogenous retinal detachment. Am J Ophthalmol. 2014 Aug;158(2):251-256
5. Cho KH, Park SJ, Woo SJ, Park KH. Correlation between Inner-retinal changes and outer-retinal damage in patients with idiopathic epiretinal membrane. Retina 2017 Oct 23.
6. Cho KH, Ahn SJ, Jung C, Han MK, Park KH, Woo SJ. The characteristics of retinal emboli and its association with vascular reperfusion in retinal artery occlusion. Invest Ophthalmol Vis Sci. 2016 Sep 1;57(11):4589-98
7. Cho KH, Kim CK, Woo SJ, Park KH, Park SJ. Cerebral Small Vessel Disease in Branch Retinal Artery Occlusion. Invest Ophthalmol Vis Sci. 2016 Oct 1;57(13):5818-5824.
8. Cho KH, Kim CK, Oh K, Oh SW, Park KH, Park SJ. Retinal Vein Occlusion as the Surrogate Marker for Premature Brain Aging in Young Patients. Invest Ophthalmol Vis Sci. 2017 May 1;58(6).
9. Cho KH, Kim J, Choi DG, Lee JY. Do the primary surgical option for basic-type exotropia cause differences in distance-near discrepancy of recurrent exotropia after surgery? PLoS One. 2019 Aug 19;14(8)
10. Cho KH, Kim HW, Choi DG, Lee JY. Type of the recurrent exotropia after bilateral rectus recession for intermittent exotropia. BMC Ophthalmol. 2016 Jul 8;16:97
11. Cho KH, Lee JY Correction of Hypertropia Coexisting with Intermittent Exotropia, J Korean Ophthalmol Soc 2014;55(12):1883-1889
12. Cho KH, Lee MJ A Case of Canaliculocele Treated with Punctoplasty and Marsupialization J Korean Ophthalmol Soc 2014;55(6):898-901
¹ÚÀ¯Á¤ ¿øÀå
ÀÇÇм®»ç / ¾È°úÀü¹®ÀÇ / ¸Á¸·Àü¹®ÀÇ
¡¤ ¼¿ï¾Æ»êº´¿ø ¿ï»ê´ëÇб³ Àǰú´ëÇÐ ¾È°úÇб³½Ç ¿Ü·¡Á¶±³¼ö¡¤ ¼¿ï¾Æ»êº´¿ø ¿ï»ê´ëÇб³ Àǰú´ëÇÐ ¾È°úÇб³½Ç ¸Á¸·Àü¹®ÀÇ
¡¤ ¼¿ï¾Æ»êº´¿ø ¾È°ú ÀÓ»ó ÀüÀÓ°»ç
¡¤ ¼¿ï¾Æ»êº´¿ø ¾È°ú Àü¹®ÀÇ
¡¤ ¼¿ï¾Æ»êº´¿ø ¼ö·ÃÀÇ
¡¤ ¿ï»ê´ëÇб³ Àǰú´ëÇÐ ´ëÇпø ¾È°úÇÐ ¼®»çÇÐÀ§ ¼ö·á
¡¤ ¿ï»ê´ëÇб³ Àǰú´ëÇÐ Á¹¾÷
¼Ò¼ÓÇÐȸ
¡¤ ´ëÇѾȰúÇÐȸ¡¤ ¹Ì±¹½Ã°úÇÐÇÐȸ (ARVO)
¡¤ À¯·´¸Á¸·ÇÐȸ (EURETINA)
¡¤ ¾Æ½Ã¾ÆÅÂÆò¾çÀ¯¸®Ã¼¸Á¸·ÇÐȸ (APVRS)
ÁÖ¿äÇÐȸ¹ßÇ¥ (1ÀúÀÚ ¹ßÇ¥)
¡¤ 2017 ¹Ì±¹¾È°úÇÐȸ (ARVO) in Baltimore¡¤ 2019 À¯·´¸Á¸·ÇÐȸ (EURETINA) in Paris
¡¤ 2019 ¾Æ½Ã¾Æ-ÅÂÆò¾ç À¯¸®Ã¼ ¸Á¸·ÇÐȸ (APVRS) in Shanghai
ÁÖ¿ä³í¹® (1ÀúÀÚ)
1. Park YJ, Lee S, Yoon YH. One-year follow-up of optical coherence tomography angiography microvascular findings: macular telangiectasia type 2 versus tamoxifen retinopathy. Graefes Arch Clin Exp Ophthalmol 20222. Hess K, Park YJ, Kim H-A, et al. Tamoxifen Retinopathy and Macular Telangiectasia Type 2: Similarities and Differences on Multimodal Retinal Imaging. Ophthalmology Retina2022.
3. Park YJ, Lim HT. A Case of Leber Hereditary Optic Neuropathy Showing Optic Disc Hyperfluorescence. J Korean Ophthalmol Soc2019;60(1):96-101.
4. Park YJ, Son GS, Kim YJ, Kim JG, Yoon YH, Lee JY. Intravitreal Anti-vascular Endothelial Growth Factor Injections to Treat Neovascular Age-related Macular Degeneration: Long-term Treatment Outcomes. J Korean Ophthalmol Soc2018;59(12):1142-1151.
Àåºñ¼Ò°³
-
Unity(À¯´ÏƼ)
Alcon»çÀÇ ÇöÁ¸ ÃÖ°íÀÇ ¹é³»Àå, ¸Á¸· ¼ö¼ú ÅëÇÕ Ç÷§Æû Àåºñ -
Artevo750
Zeiss»çÀÇ ÃÖ½ÅÇü µðÁöÅÐ ½Ã°¢È ¾È°ú Àü¹® ¹Ì¼¼¼ö¼ú Çö¹Ì°æ
°Ë»çºÎÅÍ ¼ö¼ú±îÁö µ¥ÀÌÅÍ ¿¬µ¿À¸·Î ¿Ïº®ÇÑ ¼ö¼ú °á°ú Á¦°ø -
ARGOS(¾Æ¸£°í½º)
Alcon»çÀÇ Â÷¼¼´ë Àΰø¼öÁ¤Ã¼ µµ¼ö °è»ê Á¤¹Ð °Ë»ç Àåºñ
³ôÀº Åõ°ú·ÂÀ¸·Î ½ÉÇÑ ¹é³»Àå ȯÀÚ¿¡°Ôµµ Á¤È®ÇÑ °Ë»ç °¡´É -
IOL Master 700
Zeiss»çÀÇ ¹é³»Àå ¼ö¼ú, ICL ¼ö¼ú Àü ¾È±¸ °èÃø °Ë»ç Àåºñ -
Ophthalmic Microscope Proveo 8
Leica»çÀÇ ÃÖ½ÅÇü ¾È°ú Àü¹® ¹Ì¼¼¼ö¼ú Çö¹Ì°æ -
OPMI Lumera 700(·ç¸Þ¶ó700)
Zeiss»çÀÇ ÃÖ½ÅÇü ¾È°ú Àü¹® ¹Ì¼¼¼ö¼ú Çö¹Ì°æ -
¼¾Ã߸®¿Â
Alcon»çÀÇ ´Éµ¿Çü ¾È³»¾Ð(IOP) Á¶Àý ±â´É žÀç ÃÖ»óÀ§ ¹é³»Àå ¼ö¼ú Àåºñ -
ÄܽºÅ»·¹À̼Ç
Alcon»çÀÇ Áøº¸µÈ À¯¸®Ã¼ÀýÁ¦¼ú ¹× ¹é³»Àå ¼ö¼ú ÅëÇÕ Àåºñ
-
California(͏®Æ÷´Ï¾Æ), ±¤°¢ ¾ÈÀú Ä«¸Þ¶ó
Optos»çÀÇ ¸Á¸·ÀÇ 82%(200µµ) ¿µ¿ªÀ» ÇÑ´«¿¡ °Ë»çÇÏ´Â Ãʱ¤°¢ ¾ÈÀú ÃÔ¿µ Àåºñ
-
Heidelberg spectralis OCT
¸Á¸· 10°³ÃþÀ» ¹Ì¼¼ÇÑ ´ÜÀ§±îÁö ¿Ïº®ÇÏ°Ô ºÐ¸®ÇÏ¿© Á¤¹Ð °Ë»çÇÏ´Â Áø´Ü Àåºñ -
Cirrus OCT
Zeiss»çÀÇ Àü¼¼°è Ç¥ÁØ µ¥ÀÌÅÍ·Î ¸Á¸·º´º¯, ³ì³»Àå À§Çèµµ¸¦ °´°üÀûÀ¸·Î Á¤¹Ð °üÂûÇÏ´Â Àåºñ -
OCT Angiography SPECTRALIS
Á¶¿µÁ¦ ÅõÀÔ ¾øÀÌ ÀÚ°¡Çü±¤¾ÈÀúÃÔ¿µ, ¸Á¸·´ÜÃþÃÔ¿µ, ½Ã½Å°æ¼¶À¯ÃþµÎ²² µî ´Ù¾çÇÑ ¸Á¸· ÁúȯÀ» Áø´ÜÇÏ´Â Àåºñ
-
¸Á¸·ÀüÀ§µµ°Ë»ç, ½ÃÀ¯¹ßÀüÀ§ °Ë»ç(ERG, VEP)
´«À¸·Î È®ÀÎÇÒ ¼ö ¾ø´Â ½Ã½Å°æ°ú ¸Á¸·ÀÇ ±â´ÉÀ» °Ë»ç
´«ÀÇ ½ÉÀüµµ °Ë»ç

Æò»ý°ü¸®½Ã½ºÅÛ
¹®¾È°ú´Â Áø·á¿Í ¼ö¼úÀ» ¹ÞÀ¸½Å ºÐµéÀÇ ´«°Ç°À» ÁöÄѵ帮±âÀ§ÇØ ´Ù¾çÇÑ ÇÁ·Î±×·¥À» Á¦°øÇÏ¿© µå¸³´Ï´Ù.| 1:1ÀÇ·áÁø Ã¥ÀÓÁø·á Á¦µµ | ¼ö¼úÀ» ÁýµµÇÑ ÀÇ·áÁøÀÌ Á÷Á¢ ȯÀÚÀÇ ´« °Ç°À» È®ÀÎÇÏ°í º¸ÁõÇÕ´Ï´Ù. |
| ¼ö¼ú ÈÄ ÄÉ¾î ¼ºñ½º | ¿ø³» °í°´°ü¸®ÆÀÀÌ ¼ö¼ú ÈÄ ÇØÇÇÄÝ ¹× ´ÙÀ½ ³»¿ø ¿¹¾à ¾È³»¸¦ µ½°í ÀÖ½À´Ï´Ù. |
| Á¤±â °ËÁø Á¦µµ | Á¤±âÀûÀÎ °ËÁø ÇÁ·Î±×·¥À¸·Î ´Ù¾çÇÑ ¾ÈÁúȯÀ» Á¶±â¹ß°ß, Á¶±âÄ¡·áÇÕ´Ï´Ù. |
